Source: Υπουργείο Υγείας (CY) Revision Year: 2017 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Nautisol 5mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White, round, flat, scored embossed “MC” immediate release tablets. |
Each tablet contains 5mg prochlorperazine maleate.
Excipient with known effect: lactose monohydrate. Each tablet contains 155.00 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Prochlorperazine |
Prochlorperazine belongs to the phenothiazine group. Prochlorperazine has a wide range of activity arising from its depressant actions on the CNS and its alpha-adrenergic blocking and weaker anti-muscarinic properties. It inhibits dopamine and prolactin-release-inhibitory factor, thus stimulating the release of prolactin. |
| List of Excipients |
|---|
|
The tablets also contain:
|
Tablets are packed in aluminium foil – polyvinylchloride film blisters, with a patient information leaflet, in cartons of 20, 50 or 60 tablets.
Tablets are also packed in polyvinylchloride securitainers containing 100, 500 or 1000 tablets.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
6550
Date of first authorisation: 16/11/1977
Date of renewal: 27/01/2010
| Drug | Countries | |
|---|---|---|
| NAUTISOL | Cyprus, Hong Kong |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
